Search research articles
Contact Us
Filters
Showing results (101-110 of 127) with videos related to
Page
of 13
Sort By:
Biorxiv : the Preprint Server for Biology
|
October 24, 2023
Genetic ablation of adhesion ligands averts rejection of allogeneic immune cells
Quirin Hammer, Karlo Perica, Hanna van Ooijen, et al.
Blood Advances
|
December 5, 2023
Systematic evaluation of donor-KIR/recipient-HLA interactions in HLA-matched hematopoietic cell transplantation for AML
Joshua A Fein, Roni Shouval, Elizabeth Krieger, et al.
Cell Stem Cell
|
July 9, 2024
Genetic ablation of adhesion ligands mitigates rejection of allogeneic cellular immunotherapies
Quirin Hammer, Karlo Perica, Rina M Mbofung, et al.
Cell Reports
|
April 28, 2016
Critical Role of CD2 Co-stimulation in Adaptive Natural Killer Cell Responses Revealed in NKG2C-Deficient Humans
Lisa L Liu, Johannes Landskron, Eivind H Ask, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 16, 2018
Complete Remission with Reduction of High-Risk Clones following Haploidentical NK-Cell Therapy against MDS and AML
Andreas T Björklund, Mattias Carlsten, Ebba Sohlberg, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 14, 2023
Functional SARS-CoV-2 cross-reactive CD4<sup>+</sup> T cells established in early childhood decline with age
Marion Humbert, Anna Olofsson, David Wullimann, et al.
Neuro-Oncology
|
July 11, 2026
iPSC-derived NK cell therapy induces durable responses in glioblastoma and overcomes resistance via a B7-H3-targeted tri-specific killer engager
Jian-Fang Ning, Zachary B Davis, Qudsia Zeb, et al.
Cytotherapy
|
December 9, 2025
Expanded adaptive NKG2C+ NK cells exhibit potent ADCC and functional responses against HBV-infected hepatoma cell lines
Jonida Kokiçi, Helena Arellano-Ballestero, Benjamin Hammond, et al.
Biorxiv : the Preprint Server for Biology
|
June 12, 2025
Expanded adaptive NKG2C+ NK cells exhibit potent ADCC and functional responses against HBV-infected hepatoma cell lines
Jonida Kokiçi, Helena Arellano-Ballestero, Benjamin Hammond, et al.
Nature Communications
|
November 29, 2022
Quadruple gene-engineered natural killer cells enable multi-antigen targeting for durable antitumor activity against multiple myeloma
Frank Cichocki, Ryan Bjordahl, Jodie P Goodridge, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 127) with videos related to
Sort By:
Page
of 13
Biorxiv : the Preprint Server for Biology
|
October 24, 2023
Genetic ablation of adhesion ligands averts rejection of allogeneic immune cells
Quirin Hammer, Karlo Perica, Hanna van Ooijen, et al.
Blood Advances
|
December 5, 2023
Systematic evaluation of donor-KIR/recipient-HLA interactions in HLA-matched hematopoietic cell transplantation for AML
Joshua A Fein, Roni Shouval, Elizabeth Krieger, et al.
Cell Stem Cell
|
July 9, 2024
Genetic ablation of adhesion ligands mitigates rejection of allogeneic cellular immunotherapies
Quirin Hammer, Karlo Perica, Rina M Mbofung, et al.
Cell Reports
|
April 28, 2016
Critical Role of CD2 Co-stimulation in Adaptive Natural Killer Cell Responses Revealed in NKG2C-Deficient Humans
Lisa L Liu, Johannes Landskron, Eivind H Ask, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 16, 2018
Complete Remission with Reduction of High-Risk Clones following Haploidentical NK-Cell Therapy against MDS and AML
Andreas T Björklund, Mattias Carlsten, Ebba Sohlberg, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 14, 2023
Functional SARS-CoV-2 cross-reactive CD4<sup>+</sup> T cells established in early childhood decline with age
Marion Humbert, Anna Olofsson, David Wullimann, et al.
Neuro-Oncology
|
July 11, 2026
iPSC-derived NK cell therapy induces durable responses in glioblastoma and overcomes resistance via a B7-H3-targeted tri-specific killer engager
Jian-Fang Ning, Zachary B Davis, Qudsia Zeb, et al.
Cytotherapy
|
December 9, 2025
Expanded adaptive NKG2C+ NK cells exhibit potent ADCC and functional responses against HBV-infected hepatoma cell lines
Jonida Kokiçi, Helena Arellano-Ballestero, Benjamin Hammond, et al.
Biorxiv : the Preprint Server for Biology
|
June 12, 2025
Expanded adaptive NKG2C+ NK cells exhibit potent ADCC and functional responses against HBV-infected hepatoma cell lines
Jonida Kokiçi, Helena Arellano-Ballestero, Benjamin Hammond, et al.
Nature Communications
|
November 29, 2022
Quadruple gene-engineered natural killer cells enable multi-antigen targeting for durable antitumor activity against multiple myeloma
Frank Cichocki, Ryan Bjordahl, Jodie P Goodridge, et al.
Page
of 13